Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-025000

Chief Executive Officer sold 18,360 shares at $55.21 ($1,013,564)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2025-02-19 Sale 10b5-1 −18,360 $55.21 $1,013,564 171,613 D: show line 1 in the form
Open-market sales · 18,360 sh · avg $55.21 · $1,013,564
Loading xslF345X05/ownership.xml…